Technology Assessment
Speciality
Output Type
Expected
Technology Assessment
Clopidogrel genotype testing after ischaemic stroke or transient ischaemic attack (TIA)
Speciality
Cardiovascular System, Blood and immune system
Output Type
SHTG Adaptation
Expected
31 March 2024
What were we asked to look at?
The Scottish Health Technologies Group (SHTG) has been asked to adapt the NICE diagnostics guidance on clopidogrel genotype testing after ischaemic stroke or TIA.
Why is this important?
The NICE guidance is due to be published in December 2023. The evidence base used to inform the NICE draft will be used to inform recommendations for NHSScotland.
Referred by
ANIA
Publication Status
Draft in development
